课题基金 / 基金详情

项目摘要

项目成果

ROBERT DAVID SCHREIBER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Genetic manipulation of mouse models has been an extremely productive approach to studying basic biological mechanisms. A Genetics Core has been established and has been productive during the last funding period. The RDCC proposes to continue support of the Genetics Core to provide two major services: 1) Transgenic and knockout mouse production and 2) Speed congenics. The transgenic and knockout mouse production facility provides additional services including blastocyst complementation, derivation of new embryonic stem cell lines, cryopreservation, and mouse embryonic fibroblast production. The speed congenics facility provides genome wide typing for the purposes of enhancing backcrossing of mice into defined genetic backgrounds. Thus, the facility will enhance the study of basic mechanisms underlying rheumatic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
  • 批准号:
    8887618
  • 项目类别:
  • 资助金额:
    $46.91万
  • 财政年份:
    2015
  • 负责人:
    ROBERT DAVID SCHREIBER
  • 依托单位:
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
  • 批准号:
    9031745
  • 项目类别:
  • 资助金额:
    $44.9万
  • 财政年份:
    2015
  • 负责人:
    ROBERT DAVID SCHREIBER
  • 依托单位:
Genetics Core
  • 批准号:
    8379365
  • 项目类别:
  • 资助金额:
    $23.36万
  • 财政年份:
    2012
  • 负责人:
    ROBERT DAVID SCHREIBER
  • 依托单位:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
  • 批准号:
    8234935
  • 项目类别:
  • 资助金额:
    $36.23万
  • 财政年份:
    2011
  • 负责人:
    ROBERT DAVID SCHREIBER
  • 依托单位: